SCHEMBL3132955

SCHEMBL3132955

O=C1c2ccccc2C(=O)N1CC=C1CN(C(c2ccccc2)c2ccccc2)C1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 5/20 0.52
DRD3 P35462 5/20 0.52
ALDH1A1 P00352 3/20 0.50
NPSR1 Q6W5P4 3/20 0.50
GAA P10253 2/20 0.50
POLB P06746 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
CASP3 P42574 3/20 0.45
CA12 O43570 1/20 0.39
CA9 Q16790 1/20 0.39
MAPT P10636 1/20 0.39
APP P05067 1/20 0.39
LMNA P02545 2/20 0.38
CYP3A4 P08684 2/20 0.38
HIF1A Q16665 2/20 0.38
CYP1A2 P05177 1/20 0.38
CYP2D6 P10635 1/20 0.38
CYP2C9 P11712 1/20 0.38
GMNN O75496 1/20 0.38
ABCB11 O95342 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29785562 1.00 DRD2 (0.52) DRD2DRD3ALDH1A1NPSR1GAA
SCHEMBL9837007 0.77 DRD2 (0.67) DRD2DRD3ALDH1A1NPSR1GAA
SCHEMBL9837012 0.77 DRD2 (0.67) DRD2DRD3ALDH1A1NPSR1GAA
SCHEMBL29785539 0.73 DRD2 (0.49) DRD2DRD3ALDH1A1NPSR1GAA
SCHEMBL3132074 0.73 DRD2 (0.49) DRD2DRD3ALDH1A1NPSR1GAA
SCHEMBL29785637 0.73 DRD2 (0.49) DRD2DRD3ALDH1A1NPSR1GAA
SCHEMBL3129727 0.73 DRD2 (0.49) DRD2DRD3ALDH1A1NPSR1GAA
SCHEMBL3129358 0.73 DRD2 (0.49) DRD2DRD3ALDH1A1NPSR1GAA
SCHEMBL29785564 0.73 DRD2 (0.49) DRD2DRD3ALDH1A1NPSR1GAA
SCHEMBL13797923 0.73 CASP3 (0.47) ALDH1A1CASP3CA12CA9LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010056633-A2 7-AMINO ALKYLIDENYL-HETEROCYCLIC QUINOLONES AND NAPHTHYRIDONES JANSSEN PHARMACEUTICA NV (BE) 2010-05-20 WO disclosed
US-20090156577-A1 7-AMINO ALKYLIDENYL-HETEROCYCLIC QUINOLONES AND NAPHTHYRIDONES JANSSEN PHARMACEUTICA NV (BE) 2009-06-18 US disclosed
US-20090156577-A1 7-AMINO ALKYLIDENYL-HETEROCYCLIC QUINOLONES AND NAPHTHYRIDONES JANSSEN PHARMACEUTICA NV (BE) 2009-06-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090156577-A1 7-AMINO ALKYLIDENYL-HETEROCYCLIC QUINOLONES AND NAPHTHYRIDONES NQO2, QRFPR, NQO1 DRD2 956/4885DRD3 688/4885ALDH1A1 1307/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.